Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.32
-0.07 (-0.83%)
At close: Jun 12, 2026, 4:00 PM EDT
8.00
-0.32 (-3.85%)
After-hours: Jun 12, 2026, 7:59 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Emergent BioSolutions stock have an average target of $12, which predicts a 44.23% increase from the current stock price of 8.32.
Price Target: $12 (+44.23%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Emergent BioSolutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +44.23% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
733.05M
from 742.90M
Decreased by -1.33%
Revenue Next Year
892.00M
from 733.05M
Increased by 21.68%
EPS This Year
0.95
from 1.53
Decreased by -37.91%
EPS Next Year
-0.96
from 0.95
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 746.1M | ||
| Avg | 733.1M | ||
| Low | 720.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.4% | ||
| Avg | -1.3% | ||
| Low | -3.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.95 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -37.9% | ||
| Low | - |